Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,417 results for ""Deoxycytidine""

Your Filters

Subject : antimetabolites, antineoplastic
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparing efficacy and safety of in-house gemcitabine to mitomycin for bladder instillation in intermediate-risk NMIBC.

  • Authors : Abou Chaaya C; Service d'urologie et chirurgie de la transplantation, hospices civils de Lyon, hôpital Édouard-Herriot, Lyon, France; Service d'urologie, hospices civils de Lyon, hôpital Lyon Sud, Lyon, France

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

  • Source: The French journal of urology [Fr J Urol] 2024 Dec; Vol. 34 (13), pp. 102699. Date of Electronic Publication: 2024 Jul 20.Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 9918752079106676 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Cultures derived from pancreatic cancer xenografts with long-term gemcitabine treatment produce chemoresistant secondary xenografts: Establishment of isogenic gemcitabine-sensitive and -resistant models.

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology ; Gemcitabine*

  • Source: Pathology, research and practice [Pathol Res Pract] 2024 Nov; Vol. 263, pp. 155632. Date of Electronic Publication: 2024 Oct 05.Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response.

  • Authors : Merrill NM; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Subjects: Gemcitabine* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics

  • Source: European urology [Eur Urol] 2024 Nov; Vol. 86 (5), pp. 434-444. Date of Electronic Publication: 2024 Aug 17.Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro.

  • Authors : Aydemir D; School of Medicine, Department of Medical Biochemistry, Koc University, Istanbul, Turkey. .; Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey. .

Subjects: Chitosan*/Chitosan*/Chitosan*/chemistry ; Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Nov; Vol. 397 (11), pp. 9051-9066. Date of Electronic Publication: 2024 Jun 17.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravesical Gemcitabine for Non-Muscle Invasive Bladder Cancer after Bacillus Calmette-Guerin Treatment Failure: A Prospective Study.

  • Authors : Mirzaee E; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Novin K

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Gemcitabine*

  • Source: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Sep 01; Vol. 25 (9), pp. 3173-3177. Date of Electronic Publication: 2024 Sep 01.Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea.

  • Authors : Kim GK; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.; Jo YH

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/mortality

  • Source: Investigative and clinical urology [Investig Clin Urol] 2024 Sep; Vol. 65 (5), pp. 435-441.Publisher: Korean Urological Association Country of Publication: Korea (South) NLM ID: 101674989 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma.

  • Authors : Shah A; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198-5870, USA.; Jahan R

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217097. Date of Electronic Publication: 2024 Jul 02.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance.

  • Authors : Wang X; Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China.; Su W

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Jul 25; Vol. 29 (7), pp. 269.Publisher: IMR Press Country of Publication: Singapore NLM ID: 101612996 Publication Model: Print Cited Medium: Internet ISSN: 2768-6698

Record details

Read More Add to Saved list
×
Report

Gemcitabine-Associated Hyperammonemia in a Patient With Cholangiocarcinoma.

  • Authors : Peng TR; Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical, Foundation, New Taipei City, Taiwan, Republic of China.; Wu TW

Subjects: Antimetabolites, Antineoplastic*/Antimetabolites, Antineoplastic*/Antimetabolites, Antineoplastic*/adverse effects ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/drug therapy ; Bile Duct Neoplasms*/Bile Duct Neoplasms*/Bile Duct Neoplasms*/complications

  • Source: American journal of therapeutics [Am J Ther] 2024 Jul-Aug 01; Vol. 31 (4), pp. e439-e440.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Newly identified adverse events for gemcitabine using the Food and Drug Administration Adverse Event Reporting System.

  • Authors : Zhang W; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.; Wang Y

Subjects: Gemcitabine* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jul; Vol. 23 (7), pp. 917-923. Date of Electronic Publication: 2023 Nov 20.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  3,417 results for ""Deoxycytidine""